Under the umbrella of SAHTAC and Campaigning for Cancer a first regional Health Technology Assessment International (HTAi)-endorsed workshop was held on October 26, 2022, in Johannesburg. It was co-hosted by the HTAi’s Public and Citizen Involvement working group. The workshop focused on patient and public involvement (PPI) in HTA or healthcare decision making in Southern...
On 26th October 2022, the South African Health Technologies Coalition (SAHTAC), through its Regulatory Harmonisation work, supported the South African Health Products Regulatory Authority (SAHPRA) to host a webinar titled: SAHPRA unpacks global accolade upon receiving WHO Maturity Level 3. More than 337 people dialed into the webinar which was characterized by many questions and...
SAHTAC participated in the first joint World Health Summit co-hosted with WHO on 16 to 18 October in Berlin, Germany. The Summit brought together the most prominent names in global health from all sectors in all regions of the world. Held under the patronage of German Federal Chancellor Olaf Scholz, French President Emmanuel Macron, Senegal’s...
The Covid-19 pandemic not only exposed the weaknesses in our healthcare system but also revealed the deep-seated issues that remain prevalent with pharmaceutical companies responsible for developing lifesaving technology. The deep-seated issues pertaining to access to medical resources in third-world countries, where many countries are often left behind in the process of accessing lifesaving technology....
On the 22nd of August 2022, SAHTAC held the Gender, Diversity and Inclusion workshop spearheaded by its Positioning & Capacity Building Task Team. This was done in the month of August in celebration of women and the theme was mainly to raise awareness of gender and diversity issues for coalition members. We are called to...
Across the globe, research helps find the root cause of the health challenges or diseases in our society, identify ways to improve behaviours of the affected community, and find solutions to our health issues. Clinical research has critical in bringing new vaccines to our health system. Clinical research – aimed at evaluating a medical, surgical, or...
It is time to treat the scourge of Tuberculosis scourge with the same urgency as we did the COVID-19 pandemic. As we emerge from the devastating toll of the pandemic on people’s lives and on global economies, we must wake up to face the staggering toll of 1.5 million Tuberculosis deaths and 10 million new infections...
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity NEW YORK, NY AND CAMBRIDGE, MA — MAY 18, 2022 — The nonprofit scientific research organization IAVI and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and...
On 10 May 2022 the South African Health Technologies Coalition (SAHTAC), in collaboration with the National Department of Health, and the South African HVTN, International Partnerships of Microbicides (IPM) and Advocates for Prevention of HIV in Africa (APHA) hosted a virtual webinar titled, ‘THE DAPIVIRINE VAGINAL RING GETS SAHPRA APPROVAL – A MILESTONE FOR WOMEN’S...
Across Africa, local manufacturing and pharmaceutical companies are responding to the urgent need for locally produced medical products and technologies despite the existing regulatory challenges. We can support manufacturing capacity by expediting the establishment and operationalisation of the African Medicines Agency (AMA). In November 2021, after 15 countries signed and ratified the AMA treaty, the AMA...
